Kathleen Liu

CODE-AKI: COnservative Dialysis to Enhance AKI Recovery

National Institute of Diabetes and Digestive and Kidney Diseases · R01

Contact PI · $2.8M · University of California, San Francisco

Advancing Acute Kidney Injury Phenotyping Using Biological and Clinical Criteria

National Institute of Diabetes and Digestive and Kidney Diseases · K24

Contact PI · $915.1K · University of California, San Francisco

Acute Kidney Injury: A Novel Risk Factor for Cardiovascular Events

National Institute of Diabetes and Digestive and Kidney Diseases · R01

Contact PI · $1.9M · University of California, San Francisco

Identifying Opportunities to Lower Rates of AKI and Improve Outcomes

National Institute of Diabetes and Digestive and Kidney Diseases · R01

Contact PI · $2.1M · University of California, San Francisco

I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients

Principal investigator · Active not recruiting · Phase 2

QuantumLeap Healthcare Collaborative

Liberation From Acute Dialysis

Principal investigator · Completed

University of California, San Francisco

Recovery After Dialysis-Requiring Acute Kidney Injury

Principal investigator · Terminated

University of California, San Francisco

Allogeneic HB-adMSCs vs Placebo for the Treatment of Acute Kidney Injury

Sub-investigator · Recruiting · Phase 1, Phase 2

Hope Biosciences LLC